Robert Simmons
Stock Analyst at Rosenblatt
(1.25)
# 3,498
Out of 5,182 analysts
40
Total ratings
41.67%
Success rate
-3.72%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Robert Simmons
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WDAY Workday | Maintains: Buy | $180 → $150 | $121.18 | +23.78% | 10 | Feb 25, 2026 | |
| BL BlackLine | Maintains: Buy | $62 | $31.68 | +95.71% | 3 | Feb 11, 2026 | |
| PHR Phreesia | Maintains: Buy | $36 → $34 | $9.42 | +260.93% | 6 | Apr 14, 2025 | |
| ASAN Asana | Maintains: Neutral | $20 | $6.33 | +215.96% | 6 | Mar 12, 2024 | |
| MNDY monday.com | Upgrades: Buy | $170 | $67.25 | +152.79% | 6 | Nov 7, 2023 | |
| GDRX GoodRx Holdings | Upgrades: Buy | $9.5 | $2.32 | +309.48% | 2 | Aug 10, 2023 | |
| PCTY Paylocity Holding | Upgrades: Buy | $245 | $102.27 | +139.56% | 2 | Mar 30, 2023 | |
| PAYC Paycom Software | Upgrades: Buy | $350 | $124.82 | +180.40% | 3 | Mar 30, 2023 | |
| TDOC Teladoc Health | Maintains: Buy | $45 → $40 | $6.00 | +566.67% | 2 | Oct 25, 2022 |
Workday
Feb 25, 2026
Maintains: Buy
Price Target: $180 → $150
Current: $121.18
Upside: +23.78%
BlackLine
Feb 11, 2026
Maintains: Buy
Price Target: $62
Current: $31.68
Upside: +95.71%
Phreesia
Apr 14, 2025
Maintains: Buy
Price Target: $36 → $34
Current: $9.42
Upside: +260.93%
Asana
Mar 12, 2024
Maintains: Neutral
Price Target: $20
Current: $6.33
Upside: +215.96%
monday.com
Nov 7, 2023
Upgrades: Buy
Price Target: $170
Current: $67.25
Upside: +152.79%
GoodRx Holdings
Aug 10, 2023
Upgrades: Buy
Price Target: $9.5
Current: $2.32
Upside: +309.48%
Paylocity Holding
Mar 30, 2023
Upgrades: Buy
Price Target: $245
Current: $102.27
Upside: +139.56%
Paycom Software
Mar 30, 2023
Upgrades: Buy
Price Target: $350
Current: $124.82
Upside: +180.40%
Teladoc Health
Oct 25, 2022
Maintains: Buy
Price Target: $45 → $40
Current: $6.00
Upside: +566.67%